摘要
目的验证一个新的HLA等位基因HLA-DRB11212的序列。方法采用盐析法抽提样本基因组DNA,利用HLA-DRB1组特异性引物PCR扩增先证者HLA-DRB1等位基因的第2外显子,PCR产物经割胶回收后进行测序分析,通过聚合酶链反应-序列特异性寡核苷酸探针方法验证测序发现突变点。结果先证者有两个HLA-DRB1等位基因,其中一个为HLA-DRB1090102,另一个HLA-DRB1等位基因,经BLAST验证为新的等位基因,新的等位基因序列已递交GenBank(AY899825)。与最接近的DRB1120101等位基因序列相比,新的等位基因仅在第2外显子上有1个核苷酸不同,即第199位A→C,导致第67位氨基酸Ile→Leu。结论该等位基因为新的HLA-DRB1等位基因,被世界卫生组织HLA因子命名委员会正式命名为HLA-DRB11212。
Objective To investigate the molecular genetics basis for HLA novel allele HLA-DRB1*1212 in Chinese population. Methods Genomic DNA was extracted from whole blood by salting-out method. HLA-DRB1 gene exon 2 was amplified by PCR with group-specific primers from genomic DNA. PCR products were cut back from agarose gels and purified to sequence directly. The polymerase chain reaction-sequence specific oligonucleotide probes( PCR- SSO) was performed to confirm the mutations which were detected by sequencing in this study. Results The sequencing results showed HLA-DRB1 alleles of the proband as DRB1*090102 and the novel allele. The sequences of the novel allele have been submitted to GenBank(AY899825). Through BLAST analysis, the novel 'allele was found to be different from DRB1*120101 at position 199A→C in exon 2, that results in an amino acid change from Ile to Leu at codon 67. Conclusion This allele is a novel and has been officially named as DRB1*1212 by the WHO Nomenclature Committee.
出处
《中华医学遗传学杂志》
CAS
CSCD
北大核心
2006年第1期47-49,共3页
Chinese Journal of Medical Genetics
基金
浙江省医药卫生科学研究基金(2003Z003)~~